IDEX IDEX Biometrics ASA

IDEX Biometrics Submits Registration Statement to the U.S. Securities Exchange Commission to Facilitate a Nasdaq Listing of American Depositary Shares

IDEX Biometrics Submits Registration Statement to the U.S. Securities Exchange Commission to Facilitate a Nasdaq Listing of American Depositary Shares

Oslo, Norway, 15 October 2020: IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) (the “Company”), a leading provider of advanced fingerprint identification and authentication solutions, has confidentially submitted a registration statement to the U.S. Securities and Exchange Commission (the “SEC”) in connection with a proposed listing of American Depositary Shares (“ADSs”) representing the Company’s ordinary shares on the Nasdaq Stock Market (“Nasdaq”).

The registration statement was submitted to facilitate the creation of a trading market in the United States for ADSs representing the Company’s ordinary shares. The Company is not proposing to register any new primary issuance of securities. The registration statement is subject to ongoing review by the SEC, and the proposed listing of ADSs representing the Company's ordinary shares is subject to approval by Nasdaq.

The Company's ordinary shares will continue to be admitted to trading on the Oslo Børs.

For further information contact:

Marianne Bøe, Investor Relations

E-mail:



Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer

E-mail:



Tel: 4

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger.  We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions.  Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit and follow on Twitter @IDEXBiometrics

Forward-looking Statements

Certain statements made in this announcement are forward-looking statements including with respect to the creation of a trading market for ADSs representing the Company's ordinary shares in the United States. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements including if the Company's registration statement is not declared effective by the SEC or if Nasdaq fails to approve the Company's ADS listing application. The Company cautions securityholders and prospective securityholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.



This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

EN
15/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch